| AKTing on XPO1 inhibition in AML | 2022/07/26 | English | |
| Defending health rights in a post-Roe world | 2022/07/26 | English | |
| A nano-engager for iNKT cells in cancer | 2020/11/17 | English | |
| The tightrope of science, media and politics | 2020/05/14 | English | |
| Restraining colorectal cancer with αKG | 2020/03/20 | English | |
| Prospecting whole cancer genomes | 2020/03/20 | English | |
| A key malignant switch in skin SCC | 2021/11/22 | English | |
| It’s all about communication | 2021/11/22 | English | |
| A PRC1–RNF2 knockout punch for cancer | 2021/10/22 | English | |
| Beating cancer one carbon at a time | 2022/02/28 | English | |
| Untangling the threads of immunotherapy research | 2022/03/29 | English | |
| Lethal lipotoxicity for liver cancer therapy | 2021/02/15 | English | |
| A ticking clock for B cell tumors | 2020/11/02 | English | |
| José Baselga 1959–2021 | 2021/05/05 | English | |
| Before clicking the ‘submit’ button | 2021/09/23 | English | |
| A therapy PUSh for GBM | 2021/09/23 | English | |
| One size does not fit all for mutational signatures | 2020/02/17 | English | |
| The moving target of cancer cell plasticity | 2022/09/22 | English | |
| Anything to declare? | 2023/08/24 | English | |
| Evolutionary genomic analysis for ALL | 2023/08/24 | English | |
| Aiming at different targets for immunotherapy | 2023/09/25 | English | |
| A vaccine to treat ALK+ lung cancer and prevent metastatic disease | 2023/07/10 | English | |
| To appeal or not to appeal? | 2023/06/27 | English | |
| Leveraging translational insights toward precision medicine approaches for brain metastases | 2023/07/24 | English | |
| Immunotherapy responses of patients with metastatic melanoma are linked to IL-17 signaling | 2023/08/08 | English | |
| CD8+ T cell killing of MHC class I–deficient tumors | 2023/08/03 | English | |
| ‘IL-2Rα-biased’ IL-2 for cancer immunotherapy | 2023/08/07 | English | |
| Using single-cell transcriptomics to predict which tumors will respond to targeted therapy | 2024/04/29 | English | |
| PRMT9 inhibition sparks immune responses in AML | 2024/04/29 | English | |
| CD4+ CAR T cells — more than helpers | 2023/05/29 | English | |